GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
C.r. Bard, Inc. (BCR) [hlAlert]

Rating:
Neutral BCR

C.r. Bard, Inc. (BCR) rated Neutral with price target $78 by Credit Suisse

Posted on: Monday,  Dec 21, 2009  9:25 AM ET by Credit Suisse

C.r. Bard, Inc. (NYSE: BCR)
rated Neutral with price target $78 by Credit Suisse.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/21/2009 9:25 AM Hold
None
78.33 78.00
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/7/2007 11:25 AM Hold
None
80.85 89.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy